Since 1987, Dr. William O'Riordan, founder of eStudySite, has conducted hundreds of successful Phase I through IV clinical trials for a wide range of medical and central nervous system indications. We consistently enroll among the top 2% of all participating sites for clinical studies including Bacteremia, Community-acquired pneumonia, Complicated skin and skin structure infections, MRSA, ABSSSI, Pain, Sepsis, Hospital-acquired pneumonia, Diabetes, Hepatitis, Vaccines, CV, Influenza, stroke, and many others.
eStudySite’s research team includes a full compliment of physicians, registered nurses, and research study coordinators at four separate research sites. Our team also includes highly qualified research assistants, lab technicians, site managers, independent on-site auditors, and quality assurance managers - all dedicated to providing exceptional care, ensuring patients stay the course, while adhering to the strictest clinical protocols.
eStudySite has built a solid track record for on-time completion of remarkably accurate FDA findings for sponsors, pharmaceutical companies and CROs.
Each eStudySite location is staffed with highly qualified, experienced research experts who adhere to strict quality assurance standards and protocols. Every team member undergoes a rigorous screening process and a comprehensive training program through our own quality assureance personell and our eStudySite online training program. We also have independent, proactive auditors who ensure pre-study, current- and post-study methodologies meet Good Clinical Practices (GPC) standards.
Patient safety is our highest priority and eStudySite has refined the art of total patient care, achieving industry leading retention and compliance rates.
Our study team includes Registered Nurses and Certified Clinical Research Coordinators with continuous access to the Principal Investigator and Sub-Investigator Physicians, Pharmacists, Regulatory, Administrative Staff and EMT research assistants. Along with accurate and thorough documentation, eStudySite has a history of low query rates and successful FDA audits.
Why do the world’s largest pharmaceutical and clinical research organizations turn to eStudySite for rapid enrollment and quality research?
Because providing clinical research is not a side-business for us; it’s our only business. It’s why we developed and perfected a system unmatched for efficiencies in rapidly screening and enrolling large numbers of study subjects. The benefits to sponsors and CROs are clear: speedier results and greater cost savings.
We boast one of the largest geo-diverse subject databases available. In fact, our highly characterized database system, together with our staff of well-trained expert investigators and coordinators at multiple study sites, yields the highest quality research data that will help you greatly accelerate the approval process timeline.
Put our team of critical care and research professionals to work on your next study. Take advantage of their training, experience and expertise in providing exceptional team care. Discover why we are the most efficient and productive inpatient and outpatient research site in the world.
HIPAA Compliant Database
eStudysite has deployed a revolutionary new method for quickly identifying, screening and enrolling study subjects. As a result, we offer sponsors one of the largest ethnic- and geo-diverse patient databases for a variety of diseases and indications, that, among other functions, links primary care physicians and their patients to our investigative team.
eStudySite leads the industry in making it considerably easier to quickly identify and recruit clinical research patients with the toughest indications. For example, in one study, eStudySite enrolled 24 of the sponsor’s 100 patient goal – at a single hospital site. In another complicated skin study of 1,899 subjects, eStudySite provided 465 (24%) of the patients enrolled worldwide. We also pre-bank up to 50% of our patient goal before beginning a central nervous system study (CNS).
Our patented database of hundreds of thousands of patients, along with the software program we developed to quickly identify subjects that meet exact study requirements, allows us to routinely provide larger and faster enrollments. It is the most efficient and effective system currently available, and it significantly reduces time and costs.
With the number of successful clinical trials completed and dozens more underway, eStudySite can deliver the required number of study participants faster and more efficiently, with a track record of exceeding enrollment goals.
Completed study samples include:
- ADHD - Pediatric Adult
- Acute Myocardial Infarction
- Atrial Fibrillation
- Community Acquired Pneumonia
- Complicated Skin and Skin Structure Infection
- Complicated Urinary Tract Infection
- Congestive Heart Failure
- Nocturia - Frequent Nightime Urination
- Hispanic Asthma
- Diabetes Mellitus
- Genomic DNA and Messenger RNA
- High Cholesterol
- Hospital Acquired Pneumonia
- Sepsis Syndrome
- Stroke Prevention in Patients with Atrial Fibrillation
- Uncomplicated Skin Infection
- Post-op Ileus
- Infuenza, Life-threatening flu
- Healthy Normal
Completed study samples include:
- ADHD - Pediatric & Adult
- Bipolar I and II
- Dysthymic Disorder
- Generalized Anxiety Disorder
- Insomnia - Adult & Geriatric
- Major Depressive Disorder - Adult & Geriatric
- Panic Disorder
- Post Traumatic Stress Syndrome
- Schizoaffective Disorder